Abstract
BackgroundType-2 diabetes mellitus (T2DM) is a risk factor for progressive non-alcoholic fatty liver disease (NAFLD). Drugs commonly prescribed in patients with T2DM may affect liver histology by interfering with lipid...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have